Listed on GrantGunner. Last checked 3 Nov 2026.
About this grant
Focuses on paradigm-shifting drugs, vaccines, biologics, and platform technologies to address major global health and infectious disease challenges. It supports the creation of lower-cost therapeutics and platform innovations useful for epidemic-prone viral targets. Funding is provided as equity investments, program-related investments, and grants designed for high-impact global health products.